Migraines are not just “bad headaches”; they are a complex neurological condition that can take different forms, often ...

The dad and motorcycle racer thought his lack of coordination was from being tired. It was an early ALS symptom. Now, he's ...

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in ...

Call Scheduled for August 14, 2025, at 8:30 AM Eastern Time ...

The transcranial doppler market is projected to grow at a 5.89% CAGR from 2025 to 2032, driven by rising traumatic brain injuries, neurological disorders, and sports-related injuries. Advances in AI ...

The Pennsylvania Commonwealth Court, in a recent published decision, Fee v. Prospect Medical Holdings (Workers’ Compensation ...

Ascherio said the university was able to pull together funding to pay his researchers’ salaries until next June. But he’s ...

Remember when Donald Trump celebrated mRNA-based vaccines as a “modern-day miracle”? That was before Robert F. Kennedy Jr.

This month, the snack food company headquartered on Gratiot on the city's east side will celebrate its 95th anniversary, ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

NeuroSense completed a Phase 2a clinical trial which met its safety and efficacy endpoints including reducing functional and ...

The KIT inhibitors market remains highly competitive, driven by established players such as ONO Pharmaceutical and Blueprint Medicines, among others. At the same time, companies like Celldex ...